DUBLIN, January 21, 2022–(BUSINESS WIRE)–The "Hypovolemic Shock – Epidemiology Forecast – 2032" report has been added to ResearchAndMarkets.com's offering.
The Hypovolemic Shock epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Hypovolemic Shock epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM.
The Hypovolemic Shock epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
Hypovolemic Shock Detailed Epidemiology Segmentation
The Hypovolemic Shock epidemiology covered in the report provides historical as well as forecasted Hypovolemic Shock epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.
The Hypovolemic Shock report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
Scope of the Report
The Hypovolemic Shock report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
The Hypovolemic Shock Epidemiology Report and Model provide an overview of the global trends of Hypovolemic Shock in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
The report provides insight into the historical and forecasted patient pool of Hypovolemic Shock in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
The report helps recognize the growth opportunities in the 7MM for the patient population
The report assesses the disease risk and burden and highlights the unmet needs of Hypovolemic Shock
The report provides the segmentation of the Hypovolemic Shock epidemiology
Report Highlights
11-year Forecast of Hypovolemic Shock epidemiology
7MM Coverage
Prevalent and Diagnosed Cases of Hypovolemic Shock
Cases of Hypovolemic Shock by Mutation Types
Hypovolemic Shock Cases associated with Clinical Manifestations
Key Assessments
Patient Segmentation
Disease Risk & Burden
Risk of disease by the segmentation
Factors driving growth in a specific patient population
Key Topics Covered:
1. Key Insights
2. Executive Summary of Hypovolemic Shock
3. Hypovolemic Shock: Disease Background and Overview
3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis
4. Patient Journey
5. Epidemiology and Patient Population
5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
5.3.1. Hypovolemic Shock Epidemiology Scenario in the 7MM (2019- 2032)
5.4. United States Epidemiology
5.4.1. Hypovolemic Shock Epidemiology Scenario in the United States (2019- 2032)
5.5. EU-5 Country-wise Epidemiology
5.5.1. Germany Epidemiology
5.5.1.1. Hypovolemic Shock Epidemiology Scenario in Germany (2019- 2032)
5.5.2. France Epidemiology
5.5.2.1. Hypovolemic Shock Epidemiology Scenario in France (2019- 2032)
5.5.3. Italy Epidemiology
5.5.3.1. Hypovolemic Shock Epidemiology Scenario in Italy (2019- 2032)
5.5.4. Spain Epidemiology
5.5.4.1. Hypovolemic Shock Epidemiology Scenario in Spain (2019- 2032)
5.5.5. United Kingdom Epidemiology
5.5.5.1. Hypovolemic Shock Epidemiology Scenario in the United Kingdom (2019-2032)
5.6. Japan Epidemiology
5.6.1. Hypovolemic Shock Epidemiology Scenario in Japan (2019- 2032)
6. Treatment Algorithm, Current Treatment, and Medical Practices
6.1. Hypovolemic Shock Treatment and Management
6.2. Hypovolemic Shock Treatment Algorithm
7. KOL Views
8. Unmet Needs
9. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/dmkgcv
View source version on businesswire.com: https://www.businesswire.com/news/home/20220121005164/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Mirati Therapeutics Inc (NASDAQ: MRTX) has announced data from a Phase 2 cohort of the KRYSTAL-1 study evaluating adagrasib at the 600mg BID dose in pretreated patients with pancreatic ductal adenocarcinoma and other gastrointestinal (GI) tumors. As of September 10, 2021, the subset of patients with GI cancers harboring a KRASG12C mutation enrolled in the adagrasib monotherapy arm (n=30). Of the evaluable patients (n=27), the objective response rate (ORR) was 41%, and the disease control rate (D
Radio 1 presenter Adele Roberts revealed she is undergoing chemotherapy after having surgery to remove a tumour
After fighting Ewing sarcoma, Northwest Christian sophomore defender Wilson Floyd is back on the soccer team with a clean cancer scan.
Yolanda Lopez survived stage-4 cervical cancer, but it has been an emotional battle to get this far. Late-stage cancer stole her chance to have another baby 25-years ago, but the right treatment spared her life.
While our body can detect many health ailments and inform us there's a problem we need to address by pain, there are deadly diseases that are virtually symptom-free. There are little to no warning signs with many hidden health problems, but seeing your doctor annually and taking preventive measures like yearly screenings can make a difference between life and death. Eat This, Not That! Health talked to doctors who explained what a few "silent killer" diseases are and symptoms to watch out for. R
The 54-year-old magician couldn’t contain his excitement when he took to Instagram on Monday to announce to the world that his son Johnny’s cancer is in remission six years after the 7-year-old was first diagnosed with acute lymphoblastic leukemia in 2015.
Louie Anderson, the beloved star of Baskets and Search Party, not to mention Life with Louie and Family Feud, died today at age 68, from blood cancer, according to reports. He was "in a Las Vegas hospital being treated for diffuse large B-cell lymphoma, a form of cancer," his rep Glenn Schwartz, told Rolling Stone in a statement. "More than 18,000 people are diagnosed with DLBCL each year. Despite being an aggressive lymphoma, DLBCL is considered potentially curable," according to the Lymphoma R
If you're not getting all of the necessary nutrients you need from your diet, it seems easy to turn to supplements. While this can be a solution for some people who have nutrient deficiencies, it isn't always wise to just choose a supplement and take it because you heard it's healthy for you. And in the case of some vitamins, it can even be dangerous. According to a study from Cancer Epidemiology, Biomarkers&Prevention, folic acid and vitamin B12 supplements are actually linked to an increased r
The dry patch on Nickie Murtagh's scalp turned out to be basal cell carcinoma, a form of skin cancer.
Anish Shah, managing director and chief executive officer of Mahindra Group, discusses how the coronavirus pandemic and the supply-chain disruptions are affecting the Indian conglomerate and the economy. Shah, who heads the automaker unit as well, Mahindra & Mahindra Ltd., also talks about his strategy for the business and the outlook for the industry. He speaks with Haslinda Amin and Rishaad Salamat on "Bloomberg Markets: Asia."
(Bloomberg) — Stock pickers just blew the stock rotation they’ve spent years longing for.Most Read from BloombergCrypto Crash Erases More Than $1 Trillion in Market Value‘Lethal’ U.S. Military Aid Begins Arriving in UkraineBitcoin Has Lost Half Its Value Since Hitting Record HighBitcoin Chart Hints at Possible Floor for SlideNasdaq 100’s Unrelenting Declines Ring a Dot-Com Bust Alarm BellLong underweight the booming tech megacaps in recent years, professional speculators failed to ride the Janu
MARKET PULSE Google parent Alphabet Inc. (GOOGL) (GOOG) filed a motion in federal court in New York Friday asking the court to dismiss Texas Attorney General Ken Paxton's antitrust lawsuit over Google's ad tech products.
Shares of Intuitive Surgical were falling Friday after the surgical equipment manufacturer reported earnings. Intuitive Surgical (ticker: ISRG ) reported an adjusted fourth-quarter profit of $1.30 a share, beating forecasts for $1.28 a share, on sales of $1.55 billion, which topped expectations for $1.52 billion. Covid-19 significantly disrupted surgical procedures in the fourth quarter of 2021, the company said.
On Friday, Seacoast Banking stock got a positive adjustment to its Relative Strength (RS) Rating, from 78 to 84. Banking stock has been performing well and is one sector holding up in the stock market correction. Is Seacoast Banking Stock A Buy?
Roth TSPs and Roth IRAs are similar retirement savings plans, but there are key differences that make one a better choice for you.
For the second time this month, bitcoin has dipped below $40,000, hitting $38,642 mid-way through the Asia trading session. BTC is down by nearly 11.5% in the last 24 hours. MarketGauge Group Managing Director Michelle Schneider discusses the potential catalyst behind the market sell-off and whether BTC has further room to fall.
(Bloomberg) — Argentine bonds are testing new lows as concern grows that the government will struggle to reach a refinancing deal with the International Monetary Fund before large payments come due in March.Most Read from BloombergCrypto Crash Erases More Than $1 Trillion in Market Value‘Lethal’ U.S. Military Aid Begins Arriving in UkraineBitcoin Has Lost Half Its Value Since Hitting Record HighBitcoin Chart Hints at Possible Floor for SlideNasdaq 100’s Unrelenting Declines Ring a Dot-Com Bust
South Korea's equity offering boom has created a money spinning opportunity for issuers and investors, but it has brought little cheer to at least one segment of the capital market: investment banks and brokerages working on those transactions. LG Energy Solution Ltd's (LGES) $10.8 billion initial public offering (IPO), the largest ever in South Korea, netted bankers working on the deal less than 1% of the proceeds, Dealogic data showed. Such rates make the country one of the lowest fee-paying major equity capital markets (ECM) in the world.
Also, Peloton, Netflix, TIPS, retirement advice and a look at investors’ move to value stocks. Fluctuations in the prices of building supplies are complicating construction of new homes. William Sadleir’s Aviron Films distributed movies with Halle Berry, Matthew McConaughey and Anne Hathaway.
Athersys Inc., the adult stem cell company in Cleveland, has hired a senior pharmaceutical and biotech executive as its next CEO to complete the company's efforts to commercialize its MultiStem therapy. Daniel Camardo is executive vice president, head of the rare disease and inflammation business units, and U.S. president at Horizon Therapeutics, the Irish biotech company. Camardo also will join the Athersys board.
